"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
| Descriptor ID |
D016019
|
| MeSH Number(s) |
E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
|
| Concept/Terms |
Survival Analysis- Survival Analysis
- Analysis, Survival
- Analyses, Survival
- Survival Analyses
|
Below are MeSH descriptors whose meaning is more general than "Survival Analysis".
Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".
This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 9 | 9 |
| 1996 | 0 | 9 | 9 |
| 1997 | 0 | 11 | 11 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 6 | 6 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 9 | 9 |
| 2002 | 0 | 14 | 14 |
| 2003 | 0 | 15 | 15 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 11 | 11 |
| 2006 | 0 | 14 | 14 |
| 2007 | 0 | 7 | 7 |
| 2008 | 0 | 11 | 11 |
| 2009 | 0 | 10 | 10 |
| 2010 | 0 | 8 | 8 |
| 2011 | 0 | 6 | 6 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 6 | 6 |
| 2014 | 0 | 9 | 9 |
| 2015 | 0 | 6 | 6 |
| 2016 | 0 | 5 | 5 |
| 2017 | 0 | 9 | 9 |
| 2018 | 0 | 11 | 11 |
| 2019 | 1 | 8 | 9 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Analysis" by people in Profiles.
-
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther. 2021 11; 27(11):921.e1-921.e10.
-
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era. Am J Hematol. 2021 11 01; 96(11):1374-1384.
-
Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma. Laryngoscope. 2022 03; 132(3):584-592.
-
Plasma D-dimer Does Not Anticipate the Fate of Reimplantation in Two-stage Exchange Arthroplasty for Periprosthetic Joint Infection: A Preliminary Investigation. Clin Orthop Relat Res. 2021 07 01; 479(7):1458-1468.
-
Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma. Laryngoscope. 2021 11; 131(11):E2727-E2735.
-
Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis. J Am Coll Surg. 2021 07; 233(1):39-49.
-
Laryngeal Chondrosarcoma Characteristics and Survival Analysis in the National Cancer Database. Otolaryngol Head Neck Surg. 2022 01; 166(1):101-108.
-
Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme. World Neurosurg. 2021 05; 149:e1026-e1037.
-
Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 03; 490:112956.
-
Survival curve identifies critical period for postoperative mortality in cardiac patients undergoing emergency general surgery. Sci Rep. 2020 09 23; 10(1):15499.